Comparative Bioavailability Study of a New Vitamin D3 Orodispersible Film Versus a Marketed Oral Solution in Healthy Volunteers

ConclusionThe new ODF 25000 I.U. formulation provided a valuable alternative to the marketed oral solution for therapeutic vitamin D supplementation, with a bioavailability that was slightly higher than that of the vitamin D3 oral solution administered under the same conditions.Trial RegistrationThe study was retrospectively  registered with the ISRCTN Registry (Registry code: ISRCTN13208948) on 27 November 2020.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research